BCLSI
Bain Capital Life Sciences Investors’s Savara SVRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.1M | Hold |
17,600,621
| – | – | 5.02% | 6 |
|
|
2025
Q1 | $48.8M | Buy |
17,600,621
+3,035,164
| +21% | +$8.41M | 7.21% | 6 |
|
|
2024
Q4 | $44.7M | Hold |
14,565,457
| – | – | 5.26% | 6 |
|
|
2024
Q3 | $61.8M | Hold |
14,565,457
| – | – | 6.43% | 5 |
|
|
2024
Q2 | $58.7M | Hold |
14,565,457
| – | – | 6.44% | 6 |
|
|
2024
Q1 | $72.5M | Buy |
14,565,457
+332,706
| +2% | +$1.66M | 5.83% | 7 |
|
|
2023
Q4 | $66.9M | Hold |
14,232,751
| – | – | 6.41% | 6 |
|
|
2023
Q3 | $53.8M | Buy |
14,232,751
+2,610,153
| +22% | +$9.87M | 6.02% | 6 |
|
|
2023
Q2 | $37.1M | Hold |
11,622,598
| – | – | 3.82% | 7 |
|
|
2023
Q1 | $22.7M | Hold |
11,622,598
| – | – | 2.83% | 12 |
|
|
2022
Q4 | $18M | Hold |
11,622,598
| – | – | 2.01% | 16 |
|
|
2022
Q3 | $18M | Hold |
11,622,598
| – | – | 2.15% | 17 |
|
|
2022
Q2 | $17.7M | Hold |
11,622,598
| – | – | 2.07% | 15 |
|
|
2022
Q1 | $15.2M | Hold |
11,622,598
| – | – | 1.48% | 17 |
|
|
2021
Q4 | $14.4M | Hold |
11,622,598
| – | – | 1.14% | 19 |
|
|
2021
Q3 | $16M | Hold |
11,622,598
| – | – | 1% | 21 |
|
|
2021
Q2 | $19.8M | Hold |
11,622,598
| – | – | 1.29% | 18 |
|
|
2021
Q1 | $24.2M | Buy |
11,622,598
+6,494,005
| +127% | +$13.5M | 1.37% | 15 |
|
|
2020
Q4 | $5.9M | Hold |
5,128,593
| – | – | 0.37% | 21 |
|
|
2020
Q3 | $23M | Hold |
5,128,593
| – | – | 2.14% | 12 |
|
|
2020
Q2 | $23M | Hold |
5,128,593
| – | – | 2.41% | 10 |
|
|
2020
Q1 | $23M | Hold |
5,128,593
| – | – | 3.89% | 7 |
|
|
2019
Q4 | $23M | Buy |
+5,128,593
| New | +$23M | 3.43% | 6 |
|